Free Trial

Zynex (ZYXI) Competitors

Zynex logo
$2.10 +0.03 (+1.45%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$2.10 0.00 (0.00%)
As of 06/13/2025 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZYXI vs. NYXH, ZIMV, SMTI, SNWV, STIM, CATX, TCMD, NVRO, DRTS, and TLSI

Should you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Nyxoah (NYXH), ZimVie (ZIMV), Sanara MedTech (SMTI), SANUWAVE Health (SNWV), Neuronetics (STIM), Perspective Therapeutics (CATX), Tactile Systems Technology (TCMD), Nevro (NVRO), Alpha Tau Medical (DRTS), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.

Zynex vs. Its Competitors

Zynex (NASDAQ:ZYXI) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking.

29.7% of Zynex shares are owned by institutional investors. 49.3% of Zynex shares are owned by company insiders. Comparatively, 17.1% of Nyxoah shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Nyxoah received 11 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 73.68% of users gave Nyxoah an outperform vote while only 55.36% of users gave Zynex an outperform vote.

CompanyUnderperformOutperform
ZynexOutperform Votes
31
55.36%
Underperform Votes
25
44.64%
NyxoahOutperform Votes
42
73.68%
Underperform Votes
15
26.32%

In the previous week, Nyxoah had 7 more articles in the media than Zynex. MarketBeat recorded 8 mentions for Nyxoah and 1 mentions for Zynex. Zynex's average media sentiment score of 1.87 beat Nyxoah's score of 0.73 indicating that Zynex is being referred to more favorably in the media.

Company Overall Sentiment
Zynex Very Positive
Nyxoah Positive

Zynex currently has a consensus price target of $6.00, indicating a potential upside of 185.71%. Nyxoah has a consensus price target of $14.50, indicating a potential upside of 92.31%. Given Zynex's higher probable upside, equities analysts clearly believe Zynex is more favorable than Nyxoah.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zynex
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Zynex has higher revenue and earnings than Nyxoah. Zynex is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zynex$172.40M0.37$9.73M-$0.24-8.75
Nyxoah$4.36M58.85-$46.77M-$2.13-3.54

Zynex has a net margin of 2.49% compared to Nyxoah's net margin of -1,043.93%. Zynex's return on equity of 13.05% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
Zynex2.49% 13.05% 3.78%
Nyxoah -1,043.93%-51.68%-40.11%

Zynex has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500.

Summary

Zynex beats Nyxoah on 11 of the 18 factors compared between the two stocks.

Get Zynex News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZYXI vs. The Competition

MetricZynexElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$63.50M$3.33B$5.57B$8.50B
Dividend YieldN/A1.72%5.27%4.17%
P/E Ratio14.0019.1726.7519.66
Price / Sales0.37195.99403.98152.07
Price / Cash18.0144.0938.2534.64
Price / Book1.543.816.964.59
Net Income$9.73M$94.03M$3.23B$248.23M
7 Day Performance-3.67%6.67%-1.22%-1.07%
1 Month Performance-4.11%15.88%6.34%2.59%
1 Year Performance-76.64%31.17%33.05%13.50%

Zynex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZYXI
Zynex
2.9868 of 5 stars
$2.10
+1.4%
$6.00
+185.7%
-76.6%$63.50M$172.40M14.00770Positive News
Gap Down
NYXH
Nyxoah
2.2628 of 5 stars
$7.74
+0.9%
$14.50
+87.3%
-3.5%$263.62M$4.36M-4.14110Short Interest ↑
Analyst Revision
ZIMV
ZimVie
3.2363 of 5 stars
$9.39
+0.1%
$16.33
+73.9%
-42.1%$261.48M$443.55M-0.722,700Positive News
SMTI
Sanara MedTech
1.9504 of 5 stars
$29.07
-1.4%
$49.50
+70.3%
-4.2%$258.37M$91.57M-29.3660Positive News
Analyst Revision
SNWV
SANUWAVE Health
N/A$30.16
+8.1%
N/AN/A$258.05M$36.19M-6.6140News Coverage
High Trading Volume
STIM
Neuronetics
1.956 of 5 stars
$3.72
flat
$5.50
+47.8%
+87.6%$244.85M$89.45M-3.02180
CATX
Perspective Therapeutics
2.8366 of 5 stars
$3.23
-2.7%
$12.63
+290.9%
-70.6%$239.76M$1.43M0.0070Analyst Revision
TCMD
Tactile Systems Technology
3.7776 of 5 stars
$10.23
+1.9%
$16.00
+56.4%
-16.5%$237.83M$293.16M14.61980Positive News
NVRO
Nevro
0.1542 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-35.2%$224.32M$408.52M-3.091,090
DRTS
Alpha Tau Medical
2.9176 of 5 stars
$3.13
+3.6%
$8.00
+155.6%
+31.7%$220.29MN/A-7.2880Gap Up
High Trading Volume
TLSI
TriSalus Life Sciences
3.6034 of 5 stars
$5.59
+3.7%
$10.75
+92.3%
-10.1%$211.52M$32.14M-2.24106Positive News
Short Interest ↓
Analyst Revision
Gap Up

Related Companies and Tools


This page (NASDAQ:ZYXI) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners